Phase III Trial to Evaluate the Efficacy and Safety of Initial Combination Therapy With Gemigliptin 50mg q.d and Metformin q.d
Clinical trial NCT01787396 · COMPLETED
Trial details
- NCT number
- NCT01787396
- Sponsor
- LG Life Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2015-03-01
- Enrollment
- 433
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.